Geny Piro

Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3

Rosalinda Trovato, Alessandra Fiore, S Sartori et al. · Journal for ImmunoTherapy of Cancer · 2019 · 183 citations · Full text

HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT

Francesca Bruzzese, Alessandra Leone, Monia Rocco et al. · Journal of Cellular Physiology · 2010 · 140 citations

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy

Anna Tamburrino, Geny Piro, Carmine Carbone et al. · Frontiers in Pharmacology · 2013 · 109 citations · Full text

An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients

Geny Piro, Carmine Carbone, Ivana Cataldo et al. · Clinical Cancer Research · 2016 · 84 citations

Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer

Carmine Carbone, Geny Piro, Antonio Agostini et al. · Journal for ImmunoTherapy of Cancer · 2021 · 70 citations · Full text